← Unusual insider activity · Company hub
LLY Eli Lilly & Co.
Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.
-$16.0M net selling - trailing 90 days
0 buyers - 3 unique sellers
Historical context: No open-market activity in Sep 2026 — insiders traded in 9 of the last 24 months
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
Who is responsible
| Insider | Role | Net activity | Rows |
|---|---|---|---|
| Jonsson Patrik | EVP & President, LLY Int'l | -~$7.6M | 1 |
| Hakim Anat | EVP, GC & Secretary | -~$6.0M | 1 |
| Zakrowski Donald A | SVP, Finance, & CAO | -~$2.4M | 1 |
Transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| August 17, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | S | -6500 | 1175.1 | ~$7.6M |
| August 10, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | S | -2000 | 1185.01 | ~$2.4M |
| August 7, 2026 | Hakim Anat | EVP, GC & Secretary | S | -5000 | 1190 | ~$6.0M |
| June 10, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | S | -2500 | 1150.77 | ~$2.9M |
| May 6, 2026 | LILLY ENDOWMENT INC | — | 2 reported sale rows | 15828 | — | ~$15.8M |
| May 6, 2026 | LILLY ENDOWMENT INC | — | S | -2208 | 996.183 | ~$2.2M |
| May 6, 2026 | LILLY ENDOWMENT INC | — | S | -13620 | 995.225 | ~$13.6M |
| November 13, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | S | -1000 | 1010.5 | ~$1.0M |
| August 28, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | S | -1000 | 734.93 | ~$0.7M |
| August 15, 2025 | Montarce Lucas | EVP & CFO | P | 715 | 691.786 | ~$0.5M |
| August 13, 2025 | Alvarez Ralph | — | P | 758 | 660.254 | ~$0.5M |
| August 13, 2025 | Van Naarden Jacob | EVP & Pres., Lilly Oncology | P | 1000 | 647.36 | ~$0.6M |
| August 12, 2025 | Ricks David A | President, Chair, and CEO | P | 1632 | 644.769 | ~$1.1M |
| August 12, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | P | 1000 | 634.405 | ~$0.6M |
| August 12, 2025 | Sulzberger Gabrielle | — | P | 117 | 641.182 | ~$75K |
| August 12, 2025 | Fyrwald J Erik | — | 2 reported purchase rows | 1565 | — | ~$1.0M |
| August 12, 2025 | Fyrwald J Erik | — | P | 879 | 642.586 | ~$0.6M |
| August 12, 2025 | Fyrwald J Erik | — | P | 686 | 641.996 | ~$0.4M |
| August 11, 2025 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | S | -1250 | 627.01 | ~$0.8M |
| August 8, 2025 | JACKSON JAMERE | — | P | 200 | 639.563 | ~$0.1M |
| May 27, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | S | -1000 | 716.41 | ~$0.7M |
| May 14, 2025 | Yuffa Ilya | EVP & President, LLY Int'l | S | -1250 | 749.24 | ~$0.9M |
| March 13, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | S | -1000 | 818.24 | ~$0.8M |
| February 10, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | 3 reported sale rows | 5000 | — | ~$4.3M |
| February 10, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | S | -710 | 865.76 | ~$0.6M |
| February 10, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | S | -340 | 863.97 | ~$0.3M |
| February 10, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | S | -3950 | 862.69 | ~$3.4M |
| November 8, 2024 | Zakrowski Donald A | SVP, Finance, & CAO | S | -900 | 803.38 | ~$0.7M |